Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S, Bach C, Freire J
Institute of Organic Chemistry, Syntex Discovery Research, Palo Alto, CA 94303.
Biochim Biophys Acta. 1994 Nov 16;1209(1):130-9. doi: 10.1016/0167-4838(94)90148-1.
Human prostaglandin G/H synthase 1 and 2 were expressed in the baculovirus expression system and purified to high levels. Both enzymes were glycosylated. PGHS-1 appeared to be homogeneous by SDS-PAGE analysis but two closely migrating bands were detected in PGHS-2 preparation which were evidently due to heterogeneity in glycosylation. The amino-acid sequence of the N-termini of both isoforms indicated that the signal sequences were efficiently cleaved by the insect cells. The recombinant human PGHS-1 and PGHS-2 possessed both cyclooxygenase and peroxidase activities. Both had high affinities for arachidonate as substrate and underwent self-inactivation during catalysis. The recombinant isoforms were not pharmacologically identical, since some NSAIDs were selective inhibitors of either PGHS-1 or PGHS-2. This is the first report of high levels of expression and purification of human PGHS isoforms. The recombinant enzymes are invaluable in developing potent PGHS-2 selective inhibitors that may be efficacious anti-inflammatory drugs with no or low levels of toxicity.
人前列腺素G/H合酶1和2在杆状病毒表达系统中表达并纯化至高水平。两种酶都进行了糖基化修饰。通过SDS-PAGE分析,PGHS-1似乎是均一的,但在PGHS-2制剂中检测到两条迁移紧密的条带,这显然是由于糖基化的异质性所致。两种同工型N端的氨基酸序列表明信号序列被昆虫细胞有效切割。重组人PGHS-1和PGHS-2都具有环氧化酶和过氧化物酶活性。两者对花生四烯酸作为底物都有高亲和力,并且在催化过程中会发生自失活。重组同工型在药理学上并不相同,因为一些非甾体抗炎药是PGHS-1或PGHS-2的选择性抑制剂。这是关于人PGHS同工型高水平表达和纯化的首次报道。重组酶对于开发可能是无毒或低毒的有效抗炎药物的强效PGHS-2选择性抑制剂具有重要价值。